Seiji Matsuda Selected Research

Seiji Matsuda Research Topics

Disease

15	Urinary Tract Infections (Urinary Tract Infection) 08/2006 - 08/2002
7	Infections 01/2021 - 08/2002
3	COVID-19 04/2021 - 12/2020
3	Myasthenia Gravis 03/2012 - 04/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 05/2014
2	Ischemia 01/2015 - 01/2014
2	Osteosarcoma (Osteogenic Sarcoma) 06/2011 - 06/2006
2	Muscle Weakness 01/2008 - 04/2006
2	Hepatocellular Carcinoma (Hepatoma) 06/2004 - 09/2002
1	Spina Bifida Cystica (Spina Bifida Aperta) 04/2023
1	Neural Tube Defects (Exencephaly) 04/2023
1	TDP-43 Proteinopathies 03/2023
1	Cognitive Dysfunction 10/2022
1	Schizophrenia (Dementia Praecox) 10/2022
1	Hypercholesterolemia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Atherosclerosis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Neuroblastoma 01/2020
1	Pain (Aches) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 10/2019
1	Memory Disorders (Memory Loss) 01/2016
1	Brain Injuries (Brain Injury) 01/2015
1	Learning Disabilities (Learning Disability) 01/2015
1	Brain Diseases (Brain Disorder) 05/2014
1	Poisoning 05/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2014
1	Hearing Loss (Hearing Impairment) 05/2013
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2013
1	Parkinson Disease (Parkinson's Disease) 04/2011
1	Parkinsonian Disorders (Parkinsonism) 01/2010
1	Wounds and Injuries (Trauma) 06/2006
1	Disease Progression 06/2004
1	Demyelinating Diseases (Demyelinating Disease) 11/2002
1	Lower Urinary Tract Symptoms 09/2002

Drug/Important Bio-Agent (IBA)

15	Anti-Infective Agents (Microbicides)IBA 08/2006 - 08/2002
5	Peptides (Polypeptides)IBA 04/2023 - 05/2013
5	Anti-Bacterial Agents (Antibiotics)IBA 06/2006 - 08/2002
4	Proteins (Proteins, Gene)FDA Link 01/2008 - 09/2002
3	Ivermectin (Mectizan)FDA Link 04/2021 - 12/2020
3	muskIBA 03/2012 - 04/2006
3	AutoantibodiesIBA 03/2012 - 04/2006
2	Kainic Acid (Kainate)IBA 01/2015 - 01/2014
2	Glutamic Acid (Glutamate)FDA Link 01/2015 - 01/2014
1	Nerve Growth Factors (Neurotrophins)IBA 04/2023
1	Antipsychotic Agents (Antipsychotics)IBA 10/2022
1	CollagenIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2014
1	Carbon MonoxideIBA 05/2014
1	Cholinergic Agents (Cholinergics)IBA 05/2014
1	DystrophinIBA 01/2013
1	AntibodiesIBA 03/2012
1	fasudil (AT 877)IBA 06/2011
1	PlasticsIBA 06/2011
1	rho-Associated KinasesIBA 06/2011
1	Y 27632IBA 06/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2011
1	Zonisamide (Zonegran)FDA LinkGeneric 04/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2010
1	Phosphotransferases (Kinase)IBA 01/2008
1	TitaniumIBA 06/2006
1	OsmiumIBA 11/2002

Therapy/Procedure

3	Operative Surgical Procedures 06/2004 - 08/2002
2	Indwelling Catheters (Indwelling Catheter) 10/2003 - 08/2002
1	Therapeutics 03/2023
1	Proctectomy 10/2019
1	Cystectomy 09/2002